In accordance with ACR guidelines, allopurinol is strongly advisable as a first-line urate-reducing medication. Genetic screening is usually recommended (to get a variant referred to as HLA B*5801) prior to starting off allopurinol since the carriers of the gene are at a heightened possibility of a significant allergic response.Prevention of gout i